163 related articles for article (PubMed ID: 29847021)
1. Hemorrhagic disorders of fibrinolysis: a clinical review.
Saes JL; Schols SEM; van Heerde WL; Nijziel MR
J Thromb Haemost; 2018 May; ():. PubMed ID: 29847021
[TBL] [Abstract][Full Text] [Related]
2. Inherited disorders of the fibrinolytic pathway.
Jain S; Acharya SS
Transfus Apher Sci; 2019 Oct; 58(5):572-577. PubMed ID: 31427261
[TBL] [Abstract][Full Text] [Related]
3. Fibrinolysis and bleeding of unknown cause.
Mehic D; Pabinger I; Ay C; Gebhart J
Res Pract Thromb Haemost; 2021 May; 5(4):e12511. PubMed ID: 34027290
[TBL] [Abstract][Full Text] [Related]
4. Deficiency of plasma plasminogen activator inhibitor 1 results in hyperfibrinolytic bleeding.
Lee MH; Vosburgh E; Anderson K; McDonagh J
Blood; 1993 May; 81(9):2357-62. PubMed ID: 8481516
[TBL] [Abstract][Full Text] [Related]
5. Recognition of Plasminogen Activator Inhibitor Type 1 as the Primary Regulator of Fibrinolysis.
Urano T; Suzuki Y; Iwaki T; Sano H; Honkura N; Castellino FJ
Curr Drug Targets; 2019; 20(16):1695-1701. PubMed ID: 31309890
[TBL] [Abstract][Full Text] [Related]
6. Releasing the Brakes on the Fibrinolytic System in Pulmonary Emboli: Unique Effects of Plasminogen Activation and α2-Antiplasmin Inactivation.
Singh S; Houng A; Reed GL
Circulation; 2017 Mar; 135(11):1011-1020. PubMed ID: 28028005
[TBL] [Abstract][Full Text] [Related]
7. Enhanced fibrinolytic potential in mice with combined homozygous deficiency of alpha2-antiplasmin and PAI-1.
Dewerchin M; Collen D; Lijnen HR
Thromb Haemost; 2001 Aug; 86(2):640-6. PubMed ID: 11522016
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator inhibitor type 1 deficiency.
Mehta R; Shapiro AD
Haemophilia; 2008 Nov; 14(6):1255-60. PubMed ID: 19141166
[TBL] [Abstract][Full Text] [Related]
9. The Role of Fibrinolytic System in Health and Disease.
Kwaan HC
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563651
[TBL] [Abstract][Full Text] [Related]
10. Four cases of bleeding diathesis in children due to congenital plasminogen activator inhibitor-1 deficiency.
Minowa H; Takahashi Y; Tanaka T; Naganuma K; Ida S; Maki I; Yoshioka A
Haemostasis; 1999; 29(5):286-91. PubMed ID: 10754381
[TBL] [Abstract][Full Text] [Related]
11. Evidence for an active fibrinolytic system in normal human bone marrow.
McWilliam NA; Robbie LA; Barelle CJ; Adey G; Prasad S; Bennett B; Booth NA
Br J Haematol; 1996 Apr; 93(1):170-6. PubMed ID: 8611456
[TBL] [Abstract][Full Text] [Related]
12. Systematic elucidation of effects of tranexamic acid on fibrinolysis and bleeding during and after cardiopulmonary bypass surgery.
Kojima T; Gando S; Morimoto Y; Mashio H; Goda Y; Kawahigashi H; Kemmotsu O
Thromb Res; 2001 Dec; 104(5):301-7. PubMed ID: 11738071
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Borrelia burgdorferi-bound fibrinolytic enzymes by alpha2-antiplasmin, PAI-1 and PAI-2.
Perides G; Noring R; Klempner MS
Biochem Biophys Res Commun; 1996 Feb; 219(3):690-5. PubMed ID: 8645243
[TBL] [Abstract][Full Text] [Related]
14. Fibrinolysis in patients with a mild-to-moderate bleeding tendency of unknown cause.
Gebhart J; Kepa S; Hofer S; Koder S; Kaider A; Wolberg AS; Haslacher H; Quehenberger P; Eigenbauer E; Panzer S; Mannhalter C; Pabinger I
Ann Hematol; 2017 Mar; 96(3):489-495. PubMed ID: 28018998
[TBL] [Abstract][Full Text] [Related]
15. Elevated urokinase-type plasminogen activator level and bleeding in amyloidosis: case report and literature review.
Sane DC; Pizzo SV; Greenberg CS
Am J Hematol; 1989 May; 31(1):53-7. PubMed ID: 2495717
[TBL] [Abstract][Full Text] [Related]
16. Fibrinolysis in patients with chemotherapy-induced thrombocytopenia and the effect of platelet transfusion.
Heubel-Moenen FCJI; Henskens YMC; Verhezen PWM; Wetzels RJH; Schouten HC; Beckers EAM
J Thromb Haemost; 2019 Jul; 17(7):1073-1084. PubMed ID: 31033178
[TBL] [Abstract][Full Text] [Related]
17. Assessment and determinants of whole blood and plasma fibrinolysis in patients with mild bleeding symptoms.
Vries MJA; Macrae F; Nelemans PJ; Kuiper GJAJM; Wetzels RJH; Bowman P; Verhezen PWM; Ten Cate H; Ariëns RAS; Henskens YMC
Thromb Res; 2019 Feb; 174():88-94. PubMed ID: 30579151
[TBL] [Abstract][Full Text] [Related]
18. Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance.
Carpenter SL; Mathew P
Haemophilia; 2008 Nov; 14(6):1250-4. PubMed ID: 19141165
[TBL] [Abstract][Full Text] [Related]
19. Human plasminogen activator inhibitor-1 (PAI-1) deficiency: characterization of a large kindred with a null mutation in the PAI-1 gene.
Fay WP; Parker AC; Condrey LR; Shapiro AD
Blood; 1997 Jul; 90(1):204-8. PubMed ID: 9207454
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
